The OMLIVULT brand, founded in 2012 (United States), from
142 sister brands
and 17478 competing brands.
The OMLIVULT brand is owned by Amgen, a company listed in New York.
OMLIVULT is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.